Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX
Category Archives: CAR T-cell Therapy
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
CAR T-cell Therapy: The Nurse’s Role in Treating Patients
Elizabeth A. Weber, BSN, RN, Heather DiFilippo, MSN, CRNP and Erin Medoff, RN, MSN, APRN
A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke
Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL
CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities
Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center